Skip to content

Comparison, effect of Ophthalmic ointment tetracycline1% and erythromycin 0.5% in prophylaxis of ophthalmia Neonatorum.

Clinical Trial: Comparison, effect of Ophthalmic ointment tetracycline1% and erythromycin 0.5% in prophylaxis of ophthalmia Neonatorum.

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT201101295714N1
Enrollment
330
Registered
2011-02-27
Start date
2010-03-21
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Condition 1: neonatal conjunctivitis. Condition 2: Gonococcal conjunctivitis. Neonatal conjunctivitis Gonococcal infection of eye

Interventions

Intervention 1: 330 neonates divided in 3 equal groups. In group A one cm of ophthalmic ointment Tetracyclin 1% was applied in both eyes just one time 1 hour after birth. Intervention 2: In group B on
Prevention
Treatment - Drugs
330 neonates divided in 3 equal groups. In group A one cm of ophthalmic ointment Tetracyclin 1% was applied in both eyes just one time 1 hour after birth.
In group B one cm of ophthalmic ointment Erythromycin 0.5% was applied in both eyes just one time 1 hour after birth.
Group C was the control without medication.

Sponsors

University of Medical Sciences Vice chancellor for research, Kordistan
Lead Sponsor

Eligibility

Sex/Gender
All
Age
No minimum to 1 Years

Inclusion criteria

Inclusion criteria: The study group included neonates that born in Sanandaj Besat Hospital from march 2010 to march 2011. They were born both normal vaginal delivery and cesarean section. An inclusion criterion was neonates born in Besat hospital. Exclusion criteria was congenital ophthalmic anomalies; receiving any antibiotics 48 hours before delivery; history of PROM (during 18 hrs to delivery); and mecunium aspiration

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Neonatal conjunctivitis. Timepoint: before intervention, 1 week, 2 weeks and 4 weeks later. Method of measurement: clinical examination.

Secondary

MeasureTime frame
Allergic reaction. Timepoint: 1, 2, and 4 weeks after intervention. Method of measurement: clinical examination.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMohammad Hossein Kalantar

Kurdistan University of Medical Science

kalantar.hossein@muk.ac.ir+98 87 1328 5910

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026